Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993850 · ClinicalTrials.gov registry record · Phase 3
Sleep Disturbance and Bipolar Disorder
A Phase 3 study of Bipolar Disorder and Dyssomnias, sponsored by University of California, Berkeley.
- Completed
- Registry status
- Phase 3
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT00993850 is a Phase 3 study of Bipolar Disorder and Dyssomnias that has completed, run by University of California, Berkeley. The registered enrollment target is 52 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00993850, a Phase 3 study of Bipolar Disorder and Dyssomnias, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to evaluate a psychological intervention for individuals who suffer from sleep disturbance and bipolar disorder. We are hoping that this treatment will: (1) improve the quality of life of individuals with bipolar disorder who are suffering from sleep disturbance and (2) reduce the risk of, or help prevent, episodes.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive behavioral therapy for insomnia
- OTHER Bipolar education
Study Locations (1)
California
- University of California at Berkeley - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00993850
The ClinicalTrials.gov registry entry for NCT00993850 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (84% lower). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive behavioral therapy for insomnia is the first listed.
NCT00993850 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00993850 about?
NCT00993850 is a clinical study titled "Sleep Disturbance and Bipolar Disorder". The study aims to evaluate a psychological intervention for individuals who suffer from sleep disturbance and bipolar disorder. We are hoping that this treatment will: (1) improve the quality of life of individuals with bipolar disorder who are suffering from sleep disturbance and (2) reduce the ris...
What is the current status of trial NCT00993850?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 52 participants. The study started on 2009-10. Estimated completion is 2012-07.
What conditions does trial NCT00993850 study?
This clinical trial studies the following conditions: Bipolar Disorder, Dyssomnias.
What interventions are being tested in trial NCT00993850?
The interventions under investigation include: Cognitive behavioral therapy for insomnia (BEHAVIORAL), Bipolar education (OTHER).
Who is sponsoring clinical trial NCT00993850?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00993850 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
RECRUITING · Phase 3
-
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RECRUITING · Phase 3
-
Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
COMPLETED · Phase 3
-
Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
COMPLETED · Phase 3
-
Acute Treatment of Bipolar II Depression
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.